<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Black8damage</id>
		<title>HistoryPedia - Внесок користувача [uk]</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Black8damage"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=%D0%A1%D0%BF%D0%B5%D1%86%D1%96%D0%B0%D0%BB%D1%8C%D0%BD%D0%B0:%D0%92%D0%BD%D0%B5%D1%81%D0%BE%D0%BA/Black8damage"/>
		<updated>2026-04-23T00:36:19Z</updated>
		<subtitle>Внесок користувача</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Nk_Conditioning_in_Schizophrenia_ReviewMETHODTables_1%3F_catalog_15_studies_examining_EBC_in_men_and_women&amp;diff=266232</id>
		<title>Nk Conditioning in Schizophrenia ReviewMETHODTables 1? catalog 15 studies examining EBC in men and women</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Nk_Conditioning_in_Schizophrenia_ReviewMETHODTables_1%3F_catalog_15_studies_examining_EBC_in_men_and_women&amp;diff=266232"/>
				<updated>2017-12-20T02:13:19Z</updated>
		
		<summary type="html">&lt;p&gt;Black8damage: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Inside the evaluation of this literature, cautious focus was paid to (1) findings that take place regularly across research and across investigation groups, (2) the connection of medication status to consistent findings, (3) any sample characteristics or parametric variability (in either EBC paradigms or analyses) that may perhaps contribute to heterogeneity of findings, (4) correlates of EBC performance in men and women along the schizophrenia spectrum, and (5) the implications in the findings of this review for current systems-level and neurobiological theories of schizophrenia.reported enhanced CR amplitude in folks with schizophrenia vs. controls in CS-alone trials. In post hoc analyses of individual blocks, Forsyth and colleagues (65) discovered improved CR amplitudes in controls vs. schizophrenia and SPD in later but not earlier blocks of conditioning.Medication EffectsOf the 15 published research, 13 reported medication status and all but certainly one of these (56) incorporated facts distinct to antipsychotic medication status. In 10 of these [https://dx.doi.org/10.1089/jir.2012.0117 title= jir.2012.0117] 12 research, most participants inside the schizophrenia sample were [https://www.medchemexpress.com/CX-4945.html order Silmitasertib] currently taking antipsychotic medication. When it comes to conditioning effects, 8 of these ten research of medicated men and women reported decreased conditioning (e.g., decreased % CRs) in individuals with schizophrenia in comparison with controls (58, 61?five, 67, 68). Additionally, 3 in the 12 studies analyzed information from antipsychotic-free subsamples of individuals with schizophrenia (63, 64, 68). When Bolbecker and colleagues (63) re-analyzed their information like only the medication-free subset of men and women with schizophrenia and their age-matched controls (with a sample size in every group of n = 13, [https://www.medchemexpress.com/CPI-455.html CPI-455] comparable to other stand-alone studies of antipsychoticfree schizophrenia), they identified decreased CRs and shorter CR peak latencies in these men and women with schizophrenia ?with even bigger effect sizes than in the full sample of folks with schizophrenia. The authors reported no significant correlations in between EBC dependent variables and chlorpromazine equivalent dosages (63), as did Brown and colleagues (61). Similarly, inside a later study, Bolbecker and colleagues (64) reported no considerable differences in between schizophrenia participants medicated with antipsychotics vs. those who have been medication-free. Lastly, Coesmans and colleagues (68) reported no impact of.Nk Conditioning in Schizophrenia ReviewMETHODTables 1? catalog 15 studies examining EBC in folks with schizophrenia. These research had been 1st identified using Lubow's existing evaluation of EBC in schizophrenia. Research examining EBC in the schizophrenia spectrum published subsequent to this review had been identified employing PubMed, a resource on the National Center for Biotechnology Details (NCBI), in the National Institutes of Health's (NIH) U.S. National Library of Medicine (NLM). Numerous domains of information from these 15 research [https://dx.doi.org/10.1163/1568539X-00003152 title= 1568539X-00003152] examining EBC within the schizophrenia spectrum had been then recorded and organized, like sample traits (see Table 1), parametric properties in the EBC tasks and analyses, and big findings (see Tables two?). Within the overview of this literature, careful attention was paid to (1) findings that happen regularly across studies and across analysis groups, (two) the partnership of medication status to consistent findings, (3) any sample qualities or parametric variability (in either EBC paradigms or analyses) that could contribute to heterogeneity of findings, (four) correlates of EBC overall performance in men and women along the schizophrenia spectrum, and (five) the implications of your findings of this overview for existing systems-level and neurobiological theories of schizophrenia.reported enhanced CR amplitude in men and women with schizophrenia vs.&lt;/div&gt;</summary>
		<author><name>Black8damage</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=N_humans._Especially,_positron_emission_tomography_(PET)_studies_have_revealed_alterations&amp;diff=265844</id>
		<title>N humans. Especially, positron emission tomography (PET) studies have revealed alterations</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=N_humans._Especially,_positron_emission_tomography_(PET)_studies_have_revealed_alterations&amp;diff=265844"/>
				<updated>2017-12-18T15:03:17Z</updated>
		
		<summary type="html">&lt;p&gt;Black8damage: Створена сторінка: Moreover, issues have been raised about drawing firm conclusions with regards to EBC impairment in schizophrenia due to inconsistencies inside the analysis of E...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Moreover, issues have been raised about drawing firm conclusions with regards to EBC impairment in schizophrenia due to inconsistencies inside the analysis of EBC (i.e., no matter whether or not research accounted for alpha responses and spontaneous blink rate), probable group variations in processing and encoding EBC stimuli, the notorious heterogeneity [https://www.medchemexpress.com/Dacomitinib.html PF-299804] present in the diagnostic category of schizophrenia, plus the compact sample sizes and disproportionate number of male individuals with schizophrenia reported inside the literature (51). Nonetheless, inquiries nonetheless persist relating to the source of inconsistency inside the literature examining EBC in schizophrenia, particularly related for the potential effects of antipsychotic medication and heterogeneity in methodology. The objective of the present review was to conduct a thorough and integrative critique of published research of EBC within the schizophrenia spectrum. Offered Lubow's (51) findings and cautions at the same time as the conclusions of Reeb-Sutherland and Fox (52) and Bernard and Mittal (53), particular interest was paid to (1) proof of antipsychotic medication effects, (2) inconsistencies in between studies in and any systematic effects of stimulus and analysis parameters, and (three) differences in sample size and sample characteristics. Ultimately, the findings of this evaluation are interpreted inside the context of current models of schizophrenia.Frontiers in Psychiatry | www.frontiersin.orgDecember 2015 | Volume six | ArticleKent et al.Eyebli.N humans. Specifically, positron emission tomography (PET) [https://dx.doi.org/10.1186/1479-5868-9-35 title= 1479-5868-9-35] studies have revealed changes in cerebellar activation in the course of EBC (42?6), and functional magnetic resonance imaging (fMRI) BOLD activation changes in the cerebellum are regularly reported during EBC (47?0). In the initially published overview of EBC studies and schizophrenia (51), the author concluded that general the EBC findings have been inconclusive and any observed EBC deficits [https://dx.doi.org/10.1163/1568539X-00003152 title= 1568539X-00003152] may be accounted for by antipsychotic medication administration. Lubow (51) named for an explicit comparison between medicated and non-medicated men and women with schizophrenia. Also, concerns were raised about drawing firm conclusions regarding EBC impairment in schizophrenia due to inconsistencies within the analysis of EBC (i.e., no matter if or not studies accounted for alpha responses and spontaneous blink price), doable group variations in processing and encoding EBC stimuli, the notorious heterogeneity present inside the diagnostic category of schizophrenia, plus the little sample sizes and disproportionate variety of male folks with schizophrenia reported inside the literature (51). Two subsequent brief testimonials have appeared as subsections in two lately published articles, one particular reviewing EBC performance across a lot of neurodevelopmental issues (52) and a further reviewing cerebellar-related motor dysfunction in schizophrenia and high-risk populations (53). The authors of each brief critiques largely emphasized the emerging pattern of abnormal EBC overall performance in schizophrenia, citing the huge sample sizes as well as the persistent deficit in EBC performance in an unmedicated subsample reported in studies published following Lubow's (51) critique (52), as well as even more recent studies of EBC impairment in people with schizotypal personality disorder, first-degree relatives of men and women with schizophrenia, and individuals with schizophrenia that are medication-free to get a period of a number of weeks (53). Nonetheless, each groups also acknowledged the feasible function of antipsychotic medication and methodological variability within the inconsistent findings across research (52, 53).&lt;/div&gt;</summary>
		<author><name>Black8damage</name></author>	</entry>

	</feed>